XML 60 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Activities      
Net income $ 179,630 $ 21,788 $ 125,138
Depreciation and amortization 56,317 50,317 39,674
Stock-based compensation (Note 11) 19,650 18,908 6,920
Pension (income) expense (Note 15) and other charges (11,499) 2,448 10,082
Deferred income tax benefit (Note 10) 5,171 (38,850) (2,254)
Loss on asset write-down and dispositions, net 6,290 788 236
Pension contributions (Note 15) (5,032) (5,543) (5,596)
Currency exchange losses, net (Note 6) 10,255 216 8,578
Product liability expense (Note 20) 20,590 185,264 39,036
Collections on insurance receivable and notes receivable, insurance companies (Note 20) 9,516 15,443 10,853
Product liability payments (Note 20) (36,755) (39,548) (23,727)
Changes in:      
Trade receivables (38,587) 4,374 7,677
Inventories (Note 4) (67,366) (17,827) (13,645)
Accounts payable 7,585 13,299 (3,069)
Other current assets and liabilities (1,795) 823 7,749
Other noncurrent assets and liabilities 3,485 (12,755) (1,097)
Cash Flow From Operating Activities 157,455 199,145 206,555
Investing Activities      
Capital expenditures (42,553) (43,837) (48,905)
Purchase of short-term investments (Note 19) (79,542) (133,913) (199,318)
Proceeds from maturities of short-term investments (Note 19) 119,000 160,000 175,000
Acquisitions, net of cash acquired (Note 14) 0 (392,437) 0
Property disposals and other investing (1,389) (5,286) 454
Cash Flow Used In Investing Activities (4,484) (415,473) (72,769)
Financing Activities      
Payments on long-term debt (Note 12) (1,023,000) (1,346,557) (1,031,000)
Proceeds from long-term debt (Note 12) 1,010,000 1,639,733 987,000
Debt issuance costs 0 (2,106) 0
Cash dividends paid (71,497) (68,586) (66,578)
Acquisition of noncontrolling interests in consolidated subsidiaries (Note 14) 0 (13,381) 0
Distribution to noncontrolling interests (Note 14) 0 (5,632) 0
Company stock purchases (Note 7) (34,394) (6,171) (29,144)
Exercise of stock options (Note 7) 4,650 5,770 12,446
Employee stock purchase plan (Note 7) 891 855 747
Cash Flow (Used In) Provided by Financing Activities (113,350) 203,925 (126,529)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (16,631) (7,193) 1,234
Increase (decrease) in cash, cash equivalents and restricted cash 22,990 (19,596) 8,491
Beginning cash, cash equivalents and restricted cash 141,438 161,034 152,543
Ending cash, cash equivalents and restricted cash 164,428 141,438 161,034
Supplemental cash flow information:      
Cash and cash equivalents 162,902 140,895 160,672
Restricted cash included in prepaid expenses and other current assets 1,526 543 362
Total cash, cash equivalents and restricted cash 164,428 141,438 161,034
Interest paid in cash 20,740 9,288 9,856
Income tax paid in cash $ 60,491 $ 45,556 $ 61,072